Catalyst Wire Dossier Catalyst Wire Dossier

FHND1002 Granules

· Jiangsu Chia Tai Fenghai Pharmaceutical Co., Ltd.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for FHND1002 Granules, covering 2025-01-20 to 2025-01-20. Get the full timeline:

Most recent: Clinical Trial Update: Safety, Tolerability, and Pharmacokinetics of FHND1002 Granules in Healthy Adults [Phase 1]

See pricing